about
Patient adherence and persistence with Imatinib, Nilotinib, Dasatinib in clinical practice.Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district.Changes of plasma membrane properties in a human pre-T cell line undergoing apoptosis.Medication adherence and persistence in the treatment of rheumatoid arthritis with adalimumab and etanercept. Six years of analysis.Using a treatment diary to improve the medication adherence in patients with chronic myeloid leukaemia.Medication Adherence to Tyrosine Kinase Inhibitors: 2-Year Analysis of Medication Adherence to Imatinib Treatment for Chronic Myeloid Leukemia and Correlation with the Depth of Molecular Response.cAMP phosphodiesterase activity evaluation in human carcinoma of salivary glandsAdalimumab and etanercept adherence, persistence and switch in the treatment of psoriatic arthritis: 10-year real-life analysis
P50
Q34599540-CBE47413-CF8A-4EFC-9A43-6ACE6D97BD7DQ37265764-EBBEF790-035F-4786-8667-960D673485C7Q40375655-E190825F-5CF0-45F0-A12D-0AA59F88BE67Q44253482-638B41C7-1631-4BA9-91C5-E229D558A117Q49820372-AD816A00-76F5-4DD1-BAF6-34681CE6B9D6Q55022996-87925239-6507-4F0B-8B45-2988BBB3CC81Q79300771-5C47C16F-BB64-4514-8D9E-95B60AFF9D6DQ90726094-3DB37F86-6489-4DC1-8F12-9B66D1872D81
P50
description
researcher ORCID ID = 0000-0002-9105-0745
@en
wetenschapper
@nl
name
Fiorenzo Santoleri
@ast
Fiorenzo Santoleri
@en
Fiorenzo Santoleri
@es
Fiorenzo Santoleri
@nl
type
label
Fiorenzo Santoleri
@ast
Fiorenzo Santoleri
@en
Fiorenzo Santoleri
@es
Fiorenzo Santoleri
@nl
prefLabel
Fiorenzo Santoleri
@ast
Fiorenzo Santoleri
@en
Fiorenzo Santoleri
@es
Fiorenzo Santoleri
@nl
P106
P1153
23989433100
P31
P496
0000-0002-9105-0745